Multiparametric MRI in prostate cancer management

[1]  Hessel Wijkstra,et al.  Role of multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: a Delphi consensus project , 2014, BJU international.

[2]  Baris Turkbey,et al.  Comparison of endorectal coil and nonendorectal coil T2W and diffusion‐weighted MRI at 3 Tesla for localizing prostate cancer: Correlation with whole‐mount histopathology , 2014, Journal of magnetic resonance imaging : JMRI.

[3]  A. Villers.  Words of wisdom. Re: Improving detection of clinically significant prostate cancer: MRI/TRUS fusion-guided prostate biopsy. , 2014, European urology.

[4]  Baris Turkbey,et al.  Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy. , 2014, The Journal of urology.

[5]  Xuna Zhao,et al.  Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0 T , 2014, Acta radiologica.

[6]  S. Crouzet,et al.  Value of prostate multiparametric magnetic resonance imaging for predicting biopsy results in first or repeat biopsy. , 2014, Clinical radiology.

[7]  Jonathan Haber.  Issues and Controversies , 2014 .

[8]  Baris Turkbey,et al.  Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. , 2013, European urology.

[9]  Oguz Akin,et al.  Transition zone prostate cancer: incremental value of diffusion-weighted endorectal MR imaging in tumor detection and assessment of aggressiveness. , 2013, Radiology.

[10]  N. Lawrentschuk,et al.  The role of magnetic resonance imaging in the diagnosis and management of prostate cancer , 2013, BJU international.

[11]  C Allen,et al.  Prostate MRI: who, when, and how? Report from a UK consensus meeting. , 2013, Clinical radiology.

[12]  Thomas Hambrock,et al.  Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T. , 2013, European urology.

[13]  E. Kocakoç,et al.  Utility of ADC measurement on diffusion-weighted MRI in differentiation of prostate cancer, normal prostate and prostatitis. , 2013, Quantitative imaging in medicine and surgery.

[14]  Y. Ohno,et al.  Computed diffusion-weighted imaging using 3-T magnetic resonance imaging for prostate cancer diagnosis , 2013, European Radiology.

[15]  M. Wani,et al.  Endorectal coil MRI and MR-spectroscopic imaging in patients with elevated serum prostate specific antigen with negative trus transrectal ultrasound guided biopsy , 2013, Urology annals.

[16]  Hersh Chandarana,et al.  Computed diffusion-weighted imaging of the prostate at 3 T: impact on image quality and tumour detection , 2013, European Radiology.

[17]  Aytekin Oto,et al.  Seminal vesicle invasion in prostate cancer: evaluation by using multiparametric endorectal MR imaging. , 2013, Radiology.

[18]  S Fanti,et al.  The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques? , 2013, Current radiopharmaceuticals.

[19]  P. Choyke,et al.  Functional and molecular imaging of localized and recurrent prostate cancer , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  M. Reiser,et al.  Diffusion‐weighted MRI of the abdomen: Current value in clinical routine , 2013, Journal of magnetic resonance imaging : JMRI.

[21]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[22]  Mark Emberton,et al.  Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. , 2013, European urology.

[23]  P. Albers,et al.  Increased signal intensity of prostate lesions on high b-value diffusion-weighted images as a predictive sign of malignancy , 2013, European Radiology.

[24]  C. Claussen,et al.  Accuracy of preoperative endorectal MRI in predicting extracapsular extension and influence on neurovascular bundle sparing in radical prostatectomy , 2013, World Journal of Urology.

[25]  J. Babb,et al.  Impact of delay after biopsy and post-biopsy haemorrhage on prostate cancer tumour detection using multi-parametric MRI: a multi-reader study. , 2012, Clinical radiology.

[26]  Baris Turkbey,et al.  Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management. , 2012, AJR. American journal of roentgenology.

[27]  T. Scheenen,et al.  Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T. , 2012, Radiology.

[28]  M. Preston,et al.  Prostate cancer imaging: what the urologist wants to know. , 2012, Radiologic clinics of North America.

[29]  Jian-Rong Xu,et al.  Usefulness of diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer. , 2012, Academic radiology.

[30]  Baris Turkbey,et al.  Correlation of magnetic resonance imaging tumor volume with histopathology. , 2012, The Journal of urology.

[31]  Philippe Puech,et al.  MRI and surveillance , 2012, Current opinion in urology.

[32]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[33]  Mana Ishibashi,et al.  Detection and Localization of Prostate Cancer With the Targeted Biopsy Strategy Based on ADC Map: A Prospective Large-Scale Cohort Study , 2012, Journal of magnetic resonance imaging : JMRI.

[34]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[35]  Xavier Leroy,et al.  Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and grading. , 2011, Urology.

[36]  G. Haber,et al.  Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging‐targeted and systematic biopsy for significant prostate cancer detection , 2011, BJU international.

[37]  Yousef Mazaheri,et al.  Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. , 2011, Radiology.

[38]  Thomas Hambrock,et al.  Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. , 2011, Radiology.

[39]  François Cornud,et al.  Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2‐weighted, dynamic contrast‐enhanced and diffusion‐weighted imaging , 2011, BJU international.

[40]  B. Carey,et al.  Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. , 2011, European urology.

[41]  S. Verma,et al.  A clinically relevant approach to imaging prostate cancer: review. , 2011, AJR. American journal of roentgenology.

[42]  Baris Turkbey,et al.  Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? , 2011, Radiology.

[43]  R. Passariello,et al.  Modern role of magnetic resonance and spectroscopy in the imaging of prostate cancer. , 2011, Urologic oncology.

[44]  B. Konety,et al.  Prostate cancer screening: issues and controversies. , 2010, Minnesota medicine.

[45]  S. Seo,et al.  Can We Predict Real T3 Stage Prostate Cancer in Patients with Clinical T3 (cT3) Disease before Radical Prostatectomy? , 2010, Yonsei medical journal.

[46]  H. Welch,et al.  Overdiagnosis in cancer. , 2010, Journal of the National Cancer Institute.

[47]  W. Sakr,et al.  Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity. , 2010, The Journal of urology.

[48]  Kazuro Sugimura,et al.  Prostate cancer detection with 3 T MRI: Comparison of diffusion‐weighted imaging and dynamic contrast‐enhanced MRI in combination with T2‐weighted imaging , 2010, Journal of magnetic resonance imaging : JMRI.

[49]  C. Kim,et al.  High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. , 2010, AJR. American journal of roentgenology.

[50]  Y. Yamashita,et al.  Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation , 2010, European Radiology.

[51]  Xavier Leroy,et al.  Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens. , 2009, Urology.

[52]  H. Hricak,et al.  Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging. , 2009, Radiology.

[53]  Active surveillance or active treatment in localized prostate cancer? , 2009, Deutsches Arzteblatt international.

[54]  D. Dearnaley,et al.  Dynamic contrast-enhanced MRI for prostate cancer localization. , 2009, The British journal of radiology.

[55]  Kyung Ah Kim,et al.  Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study. , 2009, Radiology.

[56]  P. Gabriele,et al.  Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging , 2009, European Radiology.

[57]  Xavier Leroy,et al.  Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings , 2009, European Radiology.

[58]  E. Jeong,et al.  Characterization of tumor angiogenesis with dynamic contrast‐enhanced MRI and biodegradable macromolecular contrast agents in mice , 2008, Magnetic resonance in medicine.

[59]  Masao Fukunaga,et al.  Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. , 2008, Radiology.

[60]  E. Adang,et al.  The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. , 2008, Clinical radiology.

[61]  P. Tan,et al.  Local experience of endorectal magnetic resonance imaging of prostate with correlation to radical prostatectomy specimens. , 2008, Annals of the Academy of Medicine, Singapore.

[62]  Hiroshi Honda,et al.  Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: Correlation with stepwise histopathology , 2008, Journal of magnetic resonance imaging : JMRI.

[63]  F. Schmidt.  Meta-Analysis , 2008 .

[64]  Theodore L. DeWeese,et al.  Localized Prostate Cancer , 2007 .

[65]  Byung Kwan Park,et al.  Value of Diffusion-Weighted Imaging for the Prediction of Prostate Cancer Location at 3T Using a Phased-Array Coil: Preliminary Results , 2007, Investigative radiology.

[66]  Robert E Lenkinski,et al.  Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results. , 2007, Radiology.

[67]  A. Costello,et al.  ENDORECTAL MAGNETIC RESONANCE IMAGING STAGING OF PROSTATE CANCER , 2007, ANZ journal of surgery.

[68]  Vikas Kundra,et al.  Imaging in oncology from the University of Texas M. D. Anderson Cancer Center: diagnosis, staging, and surveillance of prostate cancer. , 2007, AJR. American journal of roentgenology.

[69]  Masoom A Haider,et al.  Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. , 2007, AJR. American journal of roentgenology.

[70]  S. Kyriazi,et al.  Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection , 2007, Acta radiologica.

[71]  Benjamin M Yeh,et al.  Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopic imaging. , 2007, AJR. American journal of roentgenology.

[72]  V. Pansadoro,et al.  Contribution of the MR spectroscopic imaging in the diagnosis of prostate cancer in the peripheral zone , 2007, Abdominal Imaging.

[73]  H. Shinmoto,et al.  Prostate cancer screening: The clinical value of diffusion‐weighted imaging and dynamic MR imaging in combination with T2‐weighted imaging , 2007, Journal of magnetic resonance imaging : JMRI.

[74]  A. Villers,et al.  Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. , 2006, The Journal of urology.

[75]  K. Stamatiou,et al.  Incidence of impalpable carcinoma of the prostate and of non‐malignant and precarcinomatous lesions in Greek male population: An autopsy study , 2006, The Prostate.

[76]  Evis Sala,et al.  Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. , 2006, Radiology.

[77]  Evis Sala,et al.  Endorectal MR imaging before salvage prostatectomy: tumor localization and staging. , 2006, Radiology.

[78]  M. Kattan,et al.  Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. , 2005, The Journal of urology.

[79]  J Alfred Witjes,et al.  Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. , 2005, Radiology.

[80]  Seong Ho Park,et al.  Wash‐in rate on the basis of dynamic contrast‐enhanced MRI: Usefulness for prostate cancer detection and localization , 2005, Journal of magnetic resonance imaging : JMRI.

[81]  R. Stephenson,et al.  Isolated seminal vesicle invasion imparts better outcomes after radical retropubic prostatectomy for clinically localized prostate cancer: prognostic stratification of pt3b disease by nodal and margin status. , 2005, Urology.

[82]  Takako Yamaguchi,et al.  Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[83]  P. Carroll,et al.  Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. , 2004, Radiology.

[84]  Jun Nakashima,et al.  Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. , 2004, Urology.

[85]  P. Tan,et al.  Phased-array magnetic resonance imaging of the prostate with correlation to radical prostatectomy specimens: local experience. , 2004, Asian journal of surgery.

[86]  Greg Schaefer,et al.  Angiogenesis in Prostate Cancer: Biology and Therapeutic Opportunities , 2004, Cancer and Metastasis Reviews.

[87]  O. Akin,et al.  Local staging of prostate cancer with endorectal surface coil MR imaging in a mid-field magnetic system. , 2003, Clinical imaging.

[88]  Robert W Veltri,et al.  Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. , 2003, The Journal of urology.

[89]  B. Issa,et al.  In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo‐planar imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[90]  Tapio Vehmas,et al.  PROSTATIC MR IMAGING , 2001 .

[91]  K. Taari,et al.  Prostatic MR imaging: Accuracy in differentiating cancer from other prostatic disorders , 2001, Acta radiologica.

[92]  J. Nunemacher,et al.  Optimal management of giant cell arteritis and polymyalgia rheumatica , 2012, Therapeutics and clinical risk management.

[93]  K. Taari,et al.  Optimal timing of post-biopsy MR imaging of the prostate. , 2001, Acta radiologica.

[94]  J Kurhanewicz,et al.  Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. , 2000, The Journal of urology.

[95]  D P Dearnaley,et al.  Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. , 2000, Clinical radiology.

[96]  D. Johnston,et al.  A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. , 2000, The Journal of urology.

[97]  P. Carroll,et al.  Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.

[98]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[99]  A comparison of transrectal ultrasonography and endorectal magnetic resonance imaging in the local staging of prostatic carcinoma , 1999, BJU international.

[100]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[101]  J R Thornbury,et al.  Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. , 1997, Radiology.

[102]  D L McCullough,et al.  Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. , 1997, The Journal of urology.

[103]  P. Carroll,et al.  Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. , 1995, Radiology.

[104]  Mariann F. Brown,et al.  Microvascularity in benign prostatic hyperplasia , 1995, The Prostate.

[105]  P. Carroll,et al.  Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils. , 1994, Radiology.

[106]  J. Montie.  Staging of prostate cancer , 1994, Cancer.

[107]  T. Stamey,et al.  Observations on the doubling time of prostate cancer. The use of serial prostate‐specific antigen in patients with untreated disease as a measure of increasing cancer volume , 1993, Cancer.

[108]  A S Whittemore,et al.  Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer , 1993, Cancer.

[109]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[110]  N. Sobol,et al.  PRELIMINARY RESULTS , 2004 .

[111]  J. E. Tanner,et al.  Spin diffusion measurements : spin echoes in the presence of a time-dependent field gradient , 1965 .

[112]  J. Lackey.  Local experience. , 1962, Public health reports.